SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-22-000851
Filing Date
2022-05-10
Accepted
2022-05-10 16:31:21
Documents
44
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e3754_10-q.htm   iXBRL 10-Q 633146
2 EXHIBIT 31.1 e3754_ex31-1.htm EX-31.1 8698
3 EXHIBIT 31.2 e3754_ex31-2.htm EX-31.2 8971
4 EXHIBIT 32.1 e3754_ex32-1.htm EX-32.1 7131
5 GRAPHIC image_001.jpg GRAPHIC 102574
6 GRAPHIC image_002.jpg GRAPHIC 94833
  Complete submission text file 0001731122-22-000851.txt   3373649

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20220331.xsd EX-101.SCH 26535
8 XBRL CALCULATION FILE avxl-20220331_cal.xml EX-101.CAL 29354
9 XBRL DEFINITION FILE avxl-20220331_def.xml EX-101.DEF 89641
10 XBRL LABEL FILE avxl-20220331_lab.xml EX-101.LAB 211509
11 XBRL PRESENTATION FILE avxl-20220331_pre.xml EX-101.PRE 160783
38 EXTRACTED XBRL INSTANCE DOCUMENT e3754_10-q_htm.xml XML 408644
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 22910209
SIC: 2836 Biological Products, (No Diagnostic Substances)